Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H008 vs lansoprazole in reflux esophagitis
CTR20201151Phase 3Completed
- Sponsor
- Nanjing Kefepin Shenghui Pharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of keverprazan in erosive esophagitis (EE), sponsored by Nanjing Kefepin Shenghui Pharmaceutical. Started Jul 2020; status: completed.
02
Drugs
keverprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20201151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201151.